Jorien Veldwijk

Dr. Jorien Veldwijk serves as Associate Professor in Health Technology Assessment at Erasmus School of Health Policy & Management, Erasmus University Rotterdam. Her research centers on patient preference quantification through discrete choice methodologies within healthcare decision-making contexts.

Her primary research domains include patient preference studies in rheumatoid arthritis, inflammatory arthritis, lung cancer, and shoulder pain management. She specializes in discrete choice experiments and stated-preference methods to evaluate treatment acceptability, side effect tolerance, and precision medicine adoption. Current work examines AI integration in colorectal cancer care and ethical implications for doctor-patient relationships.

Recent publications reveal methodological advancements in preference research transferability across populations and disease contexts. Her 2025 output demonstrates strong focus on experimental design validity, cross-cultural applicability of preference data, and practical implementation in health technology assessment frameworks.

Dr. Veldwijk actively contributes to international collaborations through the Health Technology Assessment research group, particularly in rheumatoid arthritis prevention studies and antibiotic stewardship initiatives. Her dataset contributions on at-risk populations for rheumatoid arthritis showcase applied preference research in preventive healthcare.